Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 70
Filter
1.
Pol Merkur Lekarski ; 36(213): 206-11, 2014 Mar.
Article in Polish | MEDLINE | ID: mdl-24779222

ABSTRACT

The prevalence of hyperthyroidism in women is between 0.5-2% and it is 10 times less common in men. The most common causes are Graves' disease, toxic multinodular goiter, and autonomously functioning thyroid adenoma. Rare causes of hyperthyroidisms are as follow: pituitary adenoma, autoimmune thyroiditis (Hashitoxicosis), levothyroxine overdose, inadequate iodine supplementation (including amiodaron induced hyperthyroidism, iodine-based contrast media), hCG excess (pregnancy, gestational trophoblastic disease, germ-cell tumors), drug induced hyperthyroidism, differentiated thyroid carcinomas and/or their metastases, struma ovarii, and familial nonautoimmune hyperthyroidism. This article focuses on the current data of etiopathogenesis of hyperthyroidisms. Genetic factors (like HLA-DR3,CD40, CTLA-4, PTPN22, FOXP3 CD25) and thyroid specific genes (thyroglobulin, TSHR, G(s)alpha) and environmental and endogenous factors (such as age, iodine, selenium, emotional stress, smoking, gender, pregnancy, sex hormones, fetal microchimerism, fetal growth, bacterial infections, viral infections, allergies, drugs (alemtuzumab, interferon alpha, iplimumab/tremelimumab, tyrosine kinase inhibitors, denileukindiftitox, thalidomide/lenalidomide, exposition to fallout and radiotherapy) have been described.


Subject(s)
Hyperthyroidism/classification , Hyperthyroidism/epidemiology , Age Factors , Causality , Female , Goiter/epidemiology , Graves Disease/epidemiology , Humans , Hypersensitivity/epidemiology , Hyperthyroidism/genetics , Infections/epidemiology , Male , Pregnancy , Risk Factors , Sex Distribution , Smoking/epidemiology , Stress, Psychological/epidemiology , Thyroid Neoplasms/epidemiology , Thyroiditis, Autoimmune/epidemiology
2.
In. Álvarez Sintes, Roberto. Medicina General Integral. Tomo. V. La Habana, ECIMED, 3ra.ed; 2014. , tab.
Monography in Spanish | CUMED | ID: cum-58918
3.
In. Le�n P�rez, David O. Medicina intensiva. Nutrici�n del paciente cr�tico. La Habana, Ecimed, 2013. .
Monography in Spanish | CUMED | ID: cum-54313
4.
Eur J Endocrinol ; 164(5): 801-9, 2011 May.
Article in English | MEDLINE | ID: mdl-21357288

ABSTRACT

OBJECTIVE: Few population-based studies have described the epidemiology of subtypes of hyperthyroidism. DESIGN: A prospective population-based study, monitoring two well-defined Danish cohorts in Aalborg with moderate iodine deficiency (n=311 102) and Copenhagen with only mild iodine deficiency (n=227 632). METHODS: A laboratory monitoring system identified subjects with thyroid function tests suggesting overt hyperthyroidism (low s-TSH combined with high s-thyroxine or s-triiodothyronine). For all subjects, we collected information on medical history, thyroid scintigraphy and thyroid hormone receptor antibody (TRAb) measurement. Information was used to disprove or verify primary overt hyperthyroidism and to subclassify hyperthyroidism into nosological disorders. RESULTS: From 1997 to 2000 (2 027 208 person-years of observation), we verified 1682 new cases of overt hyperthyroidism. The overall standardized incidence rate (SIR) per 100 000 person-years was 81.6, and was higher in Aalborg compared with Copenhagen (96.7 vs 60.0, P<0.001), giving an SIR ratio (SIRR (95% confidence interval (CI))) between moderate versus mild iodine-deficient areas of 1.6 (1.4-1.8). Nosological types of hyperthyroidism (percentage/SIRR (95% CI)): multinodular toxic goitre (MNTG) 44.1%/1.9 (1.6-2.2), Graves' disease (GD) 37.6%/1.2 (0.99-1.4), solitary toxic adenoma (STA) 5.7%/2.4 (1.3-3.5), 'mixed type' hyperthyroidism (TRAb-positive, scintigraphicly multinodular) 5.4%/6.0 (3.0-12), subacute thyroiditis 2.3%/0.9 (0.4-1.4), postpartum thyroid dysfunction 2.2%/1.6 (0.8-3.0), amiodarone-associated hyperthyroidism 0.8%/7.1 (1.1-65), hyperthyroidism after thyroid radiation 0.7%/12.3 (0.8-50), lithium-associated hyperthyroidism 0.7%/0.97 (0.4-4.8) and hyperthyroidism caused by various other factors 0.7%. Lifetime risk for overt hyperthyroidism was 10.5%/6.5%/2.4% (females/all/males). CONCLUSION: Hyperthyroidism was common in Denmark with MNTG and GD as dominating entities. The higher incidence of hyperthyroidism in the most iodine-deficient region was caused by higher frequency of MNTG, 'mixed-type', STA and amiodarone-associated hyperthyroidism.


Subject(s)
Goiter, Nodular/classification , Goiter, Nodular/epidemiology , Hyperthyroidism/classification , Hyperthyroidism/epidemiology , Population Surveillance , Adolescent , Adult , Aged , Aged, 80 and over , Child , Cohort Studies , Female , Goiter, Nodular/diagnosis , Graves Disease/classification , Graves Disease/diagnosis , Graves Disease/epidemiology , Humans , Hyperthyroidism/diagnosis , Male , Middle Aged , Population Surveillance/methods , Prospective Studies , Young Adult
7.
In. Alvarez Sintes, Roberto. Medicina General Integral. Vol. III Principales afecciones en los contectos familiares y social. La Habana, Ecimed, 2.ed; 2008. .
Monography in Spanish | CUMED | ID: cum-44734
8.
Rocz Panstw Zakl Hig ; 58(3): 563-7, 2007.
Article in Polish | MEDLINE | ID: mdl-18246662

ABSTRACT

The aim of this study was to estimate the concentration of total selenium in serum women with thyroid gland disease. Selenium was determined by atomic absorption spectrometry using the hydride generation method (HG-AAS). Research was determined in 94 patients with thyroid gland disease and in 28 healthy controls. Selenium concentration of serum was variously in patients than in control group and patients with different thyroid gland diseases. Concentration in control group was 0.06231 microg/ml, in goitre group--0.05612 microg/ml, in hyperthyroidism--0.07149 microg/ml and in hypothyroidism--0.09088 microg/ml.


Subject(s)
Selenium/blood , Thyroid Diseases/blood , Thyroid Diseases/classification , Women's Health , Adult , Aged , Case-Control Studies , Female , Humans , Hyperthyroidism/blood , Hyperthyroidism/classification , Hypothyroidism/blood , Hypothyroidism/classification , Middle Aged , Poland , Reference Values , Spectrophotometry, Atomic/methods
9.
Endokrynol Pol ; 57(5): 518-24, 2006.
Article in Polish | MEDLINE | ID: mdl-17133317

ABSTRACT

Except from well-known the most frequent reasons of the hyperthyroidism such as the Graves-Basedow disease, multinodular goitre and the autonomous adenoma we should also remember the other rarer illnesses leading to the excess of thyroid hormones in the serum. Authors presented the problem of atypical forms of thyrotoxicosis which run without the overproduction of thyroid hormones and are characterized by low 24 h 131 J uptake by the thyroid gland. So called masks of hyperthyroidism such as apathetic, neuromuscular, gastrointestinal and cardiovascular forms were also discussed in the article.


Subject(s)
Hyperthyroidism/classification , Hyperthyroidism/etiology , Iodine/adverse effects , Antithyroid Agents , Autoantibodies/immunology , Diagnosis, Differential , Female , Humans , Hyperthyroidism/diagnosis , Hyperthyroidism/drug therapy , Iodine/administration & dosage , Iodine/deficiency , Male , Thyroid Function Tests , Thyroid Hormones/analysis , Thyrotoxicosis/complications , Thyrotoxicosis/diagnosis , Thyrotoxicosis/drug therapy
10.
Acta Paediatr ; 95(12): 1685-7, 2006 Dec.
Article in English | MEDLINE | ID: mdl-17129985

ABSTRACT

AIM: To identify the molecular defect by which non-autoimmune subclinical hyperthyroidism was caused in a 6-mo-old infant who presented with weight loss. METHODS: Congenital non-autoimmune hyperthyroidism is caused by activating germline mutations in the thyrotropin receptor (TSHR) gene. Therefore, the TSHR gene was sequenced directly from the patient's genomic DNA. RESULTS: Molecular analysis revealed a heterozygous point mutation (S505R) in the TSHR gene as the underlying defect. CONCLUSION: A constitutively activating mutation in the TSHR gene has to be considered not only in patients with severe congenital non-autoimmune hyperthyroidism, but also in children with subclinical non-autoimmune hyperthyroidism.


Subject(s)
Hyperthyroidism/genetics , Point Mutation/genetics , Receptors, Thyrotropin/genetics , Adult , Female , Humans , Hyperthyroidism/blood , Hyperthyroidism/classification , Infant , Male , Pedigree
11.
Hormones (Athens) ; 5(2): 119-25, 2006.
Article in English | MEDLINE | ID: mdl-16807224

ABSTRACT

Over the past two decades a plethora of publications and clinical practice data have established that subclinical thyroid dysfunction is a common condition occurring much more frequently than the overt expression of thyroid disease. Subclinical hypothyroidism is considered to be the most common of these entities. However, far more common and relatively less studied is exogenous sublinical hyperthyroidism (SubHyper) caused by L-thyroxine (T4) administration to thyroidectomized or hypothyroid patients or patients with simple or nodular goiter. Despite iodination, simple goiter is still prevalent and single or multiple nodules are now detected by ultrasound screening in 25-30% of adults, who are accordingly frequently given long-term T4 treatment. Approximately half of European Endocrinologists administer T4 permanently to patients with the above entities with the aim of suppressing TSH levels. Furthermore, in the USA the Colorado Study demonstrated that 40% of patients receiving thyroid hormones had abnormal [corrected] TSH levels (i.e. lower than 0.3 or higher than 5.1 mU/L); of these, 0.9% had hyperthyroidism and 20.7% subclinical hyperthyroidism [corrected] These facts render exogenous SubHyper an everyday problem for the endocrinologist. Exogenous SubHyper differs in many aspects from endogenous, its principal difference being that it is an iatrogenic thyroid disorder induced by the endocrinologist. The management of exogenous SubHyper relies on appropriate adjustment of T4 dosage taking into consideration a) individual requirements in T4, sex, age and the presence of cardiovascular disease or other co-morbidity, b) the recognition that small changes in serum FT4 have a logarithmic effect on TSH, c) the variability of FT4-TSH interactions between individuals, d) the instability of T4 preparations and its bioavailability, and e) the values of serum FT4 and FT3 that accompany a suppressed TSH. This last parameter is of importance since it is the free thyroid hormones values in the serum that generate and reflect the thyroid metabolic state of the organism rather than the degree of TSH suppression.


Subject(s)
Hyperthyroidism/chemically induced , Thyroxine/adverse effects , Dose-Response Relationship, Drug , Humans , Hyperthyroidism/classification , Risk , Thyroxine/administration & dosage
15.
Thyroid ; 12(6): 483-7, 2002 Jun.
Article in English | MEDLINE | ID: mdl-12165110

ABSTRACT

Hyperthyroidism is a common disorder affecting multiple systems in the body. The cardiovascular effects are among the most striking. The availability of effective treatments for hyperthyroidism has led to the widespread perception that it is a reversible disorder without any long-term consequences. Recent evidence suggests, however, that there may be adverse outcomes. Long-term follow-up studies have revealed increased mortality from cardiovascular and cerebrovascular disease in those with a past history of overt hyperthyroidism treated with radioiodine, as well as those with subclinical hyperthyroidism. Thyroid hormones are known to exert direct effects on the myocardium, as well as the systemic vasculature and predispose to dysrhythmias, especially supraventricular. Atrial fibrillation (AF) is a recognized complication of overt hyperthyroidism, and subclinical hyperthyroidism is also known to be a risk factor for development of AF. Supraventricular dysrhythmias, particularly atrial fibrillation, in older patients may account for some of the excess cardiovascular and cerebrovascular mortality described, especially because AF is known to predispose to embolic phenomena.


Subject(s)
Cardiovascular Diseases/etiology , Cardiovascular Diseases/mortality , Hyperthyroidism/complications , Hyperthyroidism/mortality , Aged , Atrial Fibrillation/epidemiology , Atrial Fibrillation/etiology , Cerebrovascular Disorders/mortality , Follow-Up Studies , Hemodynamics , Humans , Hyperthyroidism/classification , Middle Aged , Morbidity , Myocardial Contraction , Risk Factors , Thyrotropin/blood
16.
Eur J Endocrinol ; 146(5): 613-8, 2002 May.
Article in English | MEDLINE | ID: mdl-11980615

ABSTRACT

OBJECTIVE: To investigate the effect of different levels of iodine intake on the prevalence of hyperthyroidism and the impact of universal salt iodization on the incidence of hyperthyroidism. DESIGN: A comparative cross-sectional and longitudinal survey was conducted in three areas with borderline iodine deficiency, mild iodine excess (previously mild iodine deficiency) and severe iodine excess. Universal salt iodization had been introduced 3 years previously except in the area with borderline iodine deficiency. METHODS: In total 16 287 inhabitants from three areas answered a questionnaire concerning the history of thyroid disease. Among them 3761 unselected subjects received further investigations including thyroid function, thyroid autoantibodies, thyroid ultrasonography and urinary iodine excretion. RESULTS: Among areas with median urinary iodine excretion of 103 microg/l, 375 microg/l and 615 microg/l (P<0.05), the prevalence of hyperthyroidism did not differ significantly (1.6%, 2% and 1.2%). The prevalence of subclinical hyperthyroidism was higher in areas with borderline iodine deficiency and mild iodine excess than in the area with severe excess iodine intake (3.7%, 3.9% and 1.1%, P<0.001). The prevalence of Graves' disease and its proportion in hyperthyroidism did not differ among areas. The incidence of hyperthyroidism did not significantly increase after the introduction of universal salt iodization. CONCLUSION: Different iodine intakes under a certain range do not affect the prevalence and type of hyperthyroidism. Subclinical hyperthyroidism is more prevalent in the iodine deficient area than in the severe iodine excessive area. In the area with mild iodine deficiency, the introduction of universal salt iodization may not be accompanied by an increased incidence of hyperthyroidism.


Subject(s)
Diet Surveys , Hyperthyroidism/epidemiology , Iodine/administration & dosage , Adolescent , Adult , Aged , Aged, 80 and over , China , Female , Goiter/epidemiology , Humans , Hyperthyroidism/classification , Hyperthyroidism/physiopathology , Incidence , Male , Middle Aged , Nutritional Status , Prevalence , Sodium Chloride, Dietary/administration & dosage
17.
J Clin Endocrinol Metab ; 86(8): 3611-7, 2001 Aug.
Article in English | MEDLINE | ID: mdl-11502786

ABSTRACT

There is little consensus regarding the most appropriate dose regimen for radioiodine (131I) in the treatment of hyperthyroidism. We audited 813 consecutive hyperthyroid patients treated with radioiodine to compare the efficacy of 2 fixed-dose regimens used within our center (185 megabequerels, 370 megabequerels) and to explore factors that may predict outcome. Patients were categorized into 3 diagnostic groups: Graves' disease, toxic nodular goiter, and hyperthyroidism of indeterminate etiology. Cure after a single dose of 131I was investigated and defined as euthyroid off all treatment for 6 months or T4 replacement for biochemical hypothyroidism in all groups. As expected, patients given a single dose of 370 megabequerels had a higher cure rate than those given 185 megabequerels, (84.6% vs. 66.6%, P < 0.0001) but an increase in hypothyroidism incidence at 1 yr (60.8% vs. 41.3%, P < 0.0001). There was no difference in cure rate between the groups with Graves' disease and those with toxic nodular goiter (69.5% vs. 71.4%; P, not significant), but Graves' patients had a higher incidence of hypothyroidism (54.5% vs. 31.7%, P < 0.0001). Males had a lower cure rate than females (67.6% vs. 76.7%, P = 0.02), whereas younger patients (<40 yr) had a lower cure rate than patients over 40 yr old (68.9% vs. 79.3%, P < 0.001). Patients with more severe hyperthyroidism (P < 0.0001) and with goiters of medium or large size (P < 0.0001) were less likely to be cured after a single dose of 131I. The use of antithyroid drugs, during a period 2 wk before or after 131I, resulted in a significant reduction in cure rate in patients given 185 megabequerels 131I (P < 0.01) but not 370 megabequerels. Logistic regression analysis showed dose, gender, goiters of medium or large size, and severity of hyperthyroidism to be significant independent prognostic factors for cure after a single dose of 131I. We have demonstrated that a single fixed dose of 370 megabequerels 131I is highly effective in curing toxic nodular hyperthyroidism as well as Graves' hyperthyroidism. Because male patients and those with more severe hyperthyroidism and medium or large-sized goiters are less likely to respond to a single dose of radioiodine, we suggest that the value of higher fixed initial doses of radioiodine should be evaluated in these patient categories with lower cure rates.


Subject(s)
Hyperthyroidism/radiotherapy , Iodine Radioisotopes/therapeutic use , Adolescent , Adult , Age Factors , Aged , Child , Cohort Studies , Female , Goiter, Nodular/radiotherapy , Graves Disease/radiotherapy , Humans , Hyperthyroidism/classification , Hypothyroidism/epidemiology , Iodine Radioisotopes/adverse effects , Male , Middle Aged , Prognosis , Radiotherapy Dosage , Retrospective Studies , Sex Characteristics , Thyroxine/blood , Treatment Outcome
18.
Z Arztl Fortbild Qualitatssich ; 95(1): 51-60, 2001 Jan.
Article in German | MEDLINE | ID: mdl-11233497

ABSTRACT

The clinical signs and symptoms of the patient are the background for further examination procedures. A dysfunction of the thyroid gland can be safely excluded when the TSH level is within the normal range. A hyperthyroidism can be proven when TSH is suppressed and T3 and T4 levels, respectively, are elevated. However, the concentrations of T3, T4 (inclusive free T3 and free T4) and TSH are not only dependent on the thyroid status, but also on various extrathyroidal influences. Therefore awareness of accompanying diseases and of medications is necessary in order to avoid errors of interpretation. Different forms of hyperthyroidism have to be distinguished. The differentiation between Graves' disease and the functional autonomy (toxic nodular goiter) is of practical importance. Several methods--apart from precise clinical examination--are helpful. When Graves' disease is suspected TSH-receptor- and TPO-antibodies should be measured and an ultrasound obtained. When an autonomy is suspected, a szintigraphy as well as ultrasound should be undertaken. The laboratory methods are of high precision and sensitivity. There use is dependent on the clinical diagnostic problem, which also determines the extend and expenditure of the diagnostic procedures. These considerations are necessary also for economical reasons.


Subject(s)
Hyperthyroidism/diagnosis , Diagnosis, Differential , Humans , Hyperthyroidism/blood , Hyperthyroidism/classification , Thyrotropin/blood , Thyroxine/blood , Triiodothyronine/blood
19.
J Clin Endocrinol Metab ; 86(2): 930-4, 2001 Feb.
Article in English | MEDLINE | ID: mdl-11158069

ABSTRACT

The etiology of Graves' disease (GD), affecting up to 2% of a population in iodine-sufficient areas, is incompletely understood. According to current thinking, the development of GD depends on complex interactions among genetic, environmental, and endogenous factors. However, the relative contributions of the genetic and environmental factors remain to be clarified. In this study we report probandwise concordance rates for GD in a new cohort of same sex twin pairs born between 1953 and 1976 (young cohort), ascertained from the nationwide population-based Danish Twin Register. To elucidate the magnitude of the genetic and environmental influence in the etiology of GD, these new twin data were pooled with our previously published twin data on GD (old cohort). The old cohort consisted of 2338 same sex twin pairs born between 1870 and 1920 who had participated in questionnaire surveys during the 1950s, 1960s, and 1970s. The young cohort included 6628 same sex twin pairs born between 1953 and 1976 who had participated in a questionnaire survey in 1994. In the young cohort there were four monozygotic (MZ) pairs and one dizygotic (DZ) pair concordant for clinically overt GD, giving an overall probandwise concordance rate of 0.35 [95% confidence interval (CI), 0.16--0.57] for MZ pairs and 0.07 (95% CI, 0.01--0.24) for DZ pairs (P < 0.02). In the combined twin cohorts there were eight MZ pairs and one DZ pair concordant for clinically overt GD, giving a crude concordance rate of 0.35 (95% CI, 0.21--0.50) for MZ pairs and 0.03 (95% CI, 0.01--0.12) for DZ pairs (P < 0.02). Model-fitting analysis on the pooled twin data showed that 79% of the liability to the development of GD is attributable to genetic factors. Individual specific environmental factors not shared by the twins could explain the remaining 21%. In conclusion, our study strongly supports the idea that genetic factors play a major role in the etiology of GD and suggest that a further search for susceptibility genes is worthwhile.


Subject(s)
Diseases in Twins/genetics , Genetic Predisposition to Disease , Graves Disease/genetics , Twins, Dizygotic , Twins, Monozygotic , Adult , Aged , Cohort Studies , Denmark , Female , Humans , Hyperthyroidism/classification , Hyperthyroidism/genetics , Male , Middle Aged , Observer Variation
20.
Med Klin (Munich) ; 95(8): 421-8, 2000 Aug 15.
Article in German | MEDLINE | ID: mdl-10985062

ABSTRACT

BACKGROUND: Classic thyrotoxicosis is defined as the clinical syndrome of hypermetabolism that results when concentrations of serum free thyroxine (fT4), serum free triiodothyronine (fT3), or both are increased and serum level of TSH is suppressed. The term of subclinical thyrotoxicosis refers to a usually asymptomatic state associated with normal serum fT4 and fT3 and low serum TSH concentrations. AIM: We describe a new entity of thyrotoxicosis under the term of "organ-selective thyrotoxicosis". This refers to patients with mild clinical symptoms of thyrotoxicosis and with a non-suppressible thyroid toxic adenomas and normal serum concentrations of fT4, fT3 and TSH. PATIENTS AND METHODS: We compared symptoms and clinical signs of thyrotoxicosis with serum levels of fT4, fT3 and TSH in 33 patients with toxic adenomas. These patients were divided into 2 groups, 19 patients had normal concentrations of serum fT3, fT4 and TSH belonging to the group of "organ-selective thyrotoxicosis", 14 patients with subclinical thyrotoxicosis were in the control group. RESULTS: In both groups, mild symptoms of thyrotoxicosis were apparent but there was no significant difference between the 2 groups detectable. Therapeutic options were discussed with the patients referring to their symptoms. We describe 1 case of a female patient, in which we carried out an alcohol obliteration of a single toxic adenoma. CONCLUSION: Biological availability of thyroid hormones in patients with toxic adenomas might be elevated in selected organs although serum levels of fT4, fT3 and TSH are normal. This might be due to an increased production rate of T4 on the one hand and a specific peripheral T4/T3 conversion rate on the other hand. This might lead to an organ-selective thyrotoxicosis in the periphery without concerning the thyrotroph, so that TSH stays within the normal range. Necessity of therapeutic interventions depends on clinical signs and symptoms.


Subject(s)
Adenoma/complications , Euthyroid Sick Syndromes/diagnosis , Hyperthyroidism/diagnosis , Hyperthyroidism/physiopathology , Thyroid Gland/physiopathology , Thyroid Hormones/blood , Thyroid Neoplasms/complications , Adenoma/blood , Adenoma/physiopathology , Adult , Aged , Diagnosis, Differential , Euthyroid Sick Syndromes/blood , Euthyroid Sick Syndromes/physiopathology , Female , Humans , Hyperthyroidism/blood , Hyperthyroidism/classification , Male , Middle Aged , Prospective Studies , Thyroid Gland/metabolism , Thyroid Neoplasms/blood , Thyroid Neoplasms/physiopathology , Thyrotropin/blood , Thyrotropin-Releasing Hormone/blood , Thyroxine/blood , Triiodothyronine/blood
SELECTION OF CITATIONS
SEARCH DETAIL
...